Keiko Yamamoto

6.4k total citations
155 papers, 3.1k citations indexed

About

Keiko Yamamoto is a scholar working on Neurology, Molecular Biology and Surgery. According to data from OpenAlex, Keiko Yamamoto has authored 155 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 31 papers in Molecular Biology and 27 papers in Surgery. Recurrent topics in Keiko Yamamoto's work include Neuroblastoma Research and Treatments (34 papers), Acute Myeloid Leukemia Research (11 papers) and Neuroendocrine Tumor Research Advances (11 papers). Keiko Yamamoto is often cited by papers focused on Neuroblastoma Research and Treatments (34 papers), Acute Myeloid Leukemia Research (11 papers) and Neuroendocrine Tumor Research Advances (11 papers). Keiko Yamamoto collaborates with scholars based in Japan, United States and United Kingdom. Keiko Yamamoto's co-authors include Ryoji Hanada, Yasuhide Hayashi, Y Hayashi, Junko Takita, Toshiya Inaba, Noboru Nagahara, Akira Kikuchi, Masako Tanimura, Jun Yokota and Masataka Ichikawa and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Keiko Yamamoto

144 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiko Yamamoto Japan 33 1.2k 1.1k 582 492 360 155 3.1k
Mario Kornfeld United States 29 756 0.6× 1.2k 1.0× 350 0.6× 248 0.5× 225 0.6× 76 3.2k
Raj Murali United States 30 991 0.9× 452 0.4× 323 0.6× 277 0.6× 278 0.8× 89 2.6k
Hua Li China 30 1.0k 0.9× 272 0.2× 421 0.7× 397 0.8× 374 1.0× 103 2.8k
Katsunori Fujii Japan 33 1.3k 1.2× 1.5k 1.3× 180 0.3× 146 0.3× 512 1.4× 179 3.8k
Toyohiro Tada Japan 29 1.0k 0.9× 273 0.2× 408 0.7× 206 0.4× 322 0.9× 103 2.5k
Noriko Kimura Japan 29 767 0.7× 647 0.6× 839 1.4× 968 2.0× 506 1.4× 188 4.6k
Maria Chiara Zatelli Italy 42 1.2k 1.1× 912 0.8× 1.1k 2.0× 951 1.9× 212 0.6× 183 5.0k
Antonio Bellastella Italy 42 765 0.7× 400 0.4× 348 0.6× 160 0.3× 381 1.1× 160 4.9k
James H. Garvin United States 32 722 0.6× 757 0.7× 544 0.9× 73 0.1× 632 1.8× 127 3.2k
Antonio Agostino Sinisi Italy 36 639 0.5× 298 0.3× 270 0.5× 242 0.5× 386 1.1× 118 3.3k

Countries citing papers authored by Keiko Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Keiko Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Yamamoto more than expected).

Fields of papers citing papers by Keiko Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Yamamoto. The network helps show where Keiko Yamamoto may publish in the future.

Co-authorship network of co-authors of Keiko Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Yamamoto. A scholar is included among the top collaborators of Keiko Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Yamamoto. Keiko Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chek, Min Fey, Keiko Yamamoto, Hideki Shigematsu, et al.. (2025). Structural basis of a GatC ortholog transporter in the bacterial phosphotransferase system. FEBS Letters. 599(16). 2377–2387.
3.
Nishimura, Yusuke, Masayoshi Ono, Naoto Okubo, et al.. (2023). Application of polyglycolic acid sheets and basic fibroblast growth factor to prevent esophageal stricture after endoscopic submucosal dissection in pigs. Journal of Gastroenterology. 58(11). 1094–1104. 6 indexed citations
4.
Watanabe, Yûsuke, Keiko Yamamoto, Masayoshi Ono, et al.. (2023). Novel endoscopic management of gastroenterological anastomosis leakage by injecting gel-forming solutions: an experimental animal study. Surgical Endoscopy. 37(10). 8029–8034. 1 indexed citations
5.
Ono, Shoko, et al.. (2023). Quantitative diagnostic algorithm using endocytoscopy for superficial nonampullary duodenal epithelial tumors. Journal of Gastroenterology and Hepatology. 38(9). 1496–1502. 1 indexed citations
6.
George, Joshy, Yaohui Chen, Nourhan Abdelfattah, et al.. (2022). Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors. Cancer Research Communications. 2(6). 402–416. 5 indexed citations
7.
Ono, Shoko, Yoshiyuki Watanabe, Hiroyuki Yamamoto, et al.. (2022). Long‐term changes in aberrant DNA methylation and gastritis after Helicobacter pylori eradication focused on metachronous gastric cancer. Helicobacter. 27(5). e12915–e12915. 1 indexed citations
8.
Nishio, Shin, Kan Yonemori, Tomoka Usami, et al.. (2022). Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826. Cancer Science. 113(11). 3877–3887. 23 indexed citations
9.
Ono, Shoko, et al.. (2022). Bleeding After Gastric Endoscopic Submucosal Dissection Focused on Management of Xa Inhibitors. Journal of the Korean Gastric Cancer Association. 22(1). 47–47. 3 indexed citations
10.
Yamamoto, Keiko, et al.. (2021). Cortisol changes in bottlenose dolphins in the dolphin interactive program. Jūigaku kenkyū/Japanese journal of veterinary research. 69(2). 99–108. 3 indexed citations
11.
Kojima, Hajime, Tokio Nakada, Akiko Yagami, et al.. (2021). A Step-by-Step Approach for Assessing Human Skin Irritation Without Animal Testing for Quasi-Drugs and Cosmetic Products. 7(3). 144–154. 1 indexed citations
12.
Nishio, Shin, Koji Matsumoto, Kazuhiro Takehara, et al.. (2020). Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100. Cancer Science. 111(4). 1324–1332. 31 indexed citations
13.
Park, Hee Jung, Joshy George, Keiko Yamamoto, et al.. (2017). S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Cancer Research. 77(19). 5360–5373. 92 indexed citations
14.
Yamaguchi, Satoshi, Jiro Kitamura, & Keiko Yamamoto. (2012). [Evaluation of motor block of the lower legs in continuous lumbar epidural infusion of ropivacaine].. PubMed. 61(6). 583–7.
16.
Yokoyama, Tomoko, et al.. (2010). Proteomic profiling of human neutrophils in relation to immunoglobulin G Fc receptor IIIb polymorphism. Journal of Periodontal Research. 45(6). 780–787. 4 indexed citations
17.
Kaneko, Michio, Yoshiaki Tsuchida, Hideo Mugishima, et al.. (2002). Intensified Chemotherapy Increases the Survival Rates in Patients With Stage 4 Neuroblastoma With MYCN Amplification. Journal of Pediatric Hematology/Oncology. 24(8). 613–621. 83 indexed citations
18.
Kiya, Katsuzo, Hideki Satoh, Tatsuya Mizoue, Keiko Yamamoto, & Toshinori Matsushige. (2002). Evaluation of the Obstructed Perforating Artery after Surgery of Anterior Communicating Artery Aneurysm.. Surgery for Cerebral Stroke. 30(2). 107–113. 1 indexed citations
19.
Kikuchi, Akira, Ryoji Hanada, Ryoichi Ono, et al.. (2000). The Treatment Outcome of Acute Megakaryocytic Leukemia in Down Syndrome. 14(2). 68–71. 1 indexed citations
20.
Shiiba, Kenichi, Akira Ouchi, Keiko Yamamoto, et al.. (1993). A randomized trial of intrahepatic infusion chemotherapy for unresectable colorectal liver metastases. Gan to kagaku ryōhō. 20(11). 1531–1534. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026